ENTA EBITDA Margin
Enanta Pharmaceuticals Inc · EBITDA Margin
ENTA EBITDA Margin
Latest reported-69.43%period ending
ENTA TTM EBITDA Margin (54.19% → -69.43%)
TTM ebitda margin
High-resolution chart · PNG
ENTA ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -69.4275% | |
| -67.2634% | |
| -88.1278% | |
| -109.1207% | |
| -127.1657% | |
| -135.1426% | |
| -141.7924% | |
| -154.5235% | |
| -144.6401% | |
| -159.4037% | |
| -169.668% | |
| -155.8962% | |
| -153.1946% | |
| -151.1444% | |
| -144.2062% | |
| -138.4065% | |
| -141.0902% | |
| -139.0452% | |
| -132.7289% | |
| -108.646% | |
| -94.4641% | |
| -86.1352% | |
| -62.1746% | |
| -31.0232% | |
| -7.8579% | |
| 8.4023% | |
| 13.4314% | |
| 19.4915% | |
| 30.6605% | |
| 36.9444% | |
| 43.7991% | |
| 43.9666% | |
| 51.3553% | |
| 45.1207% | |
| 36.9853% | |
| 26.5402% | |
| -74.8439% | |
| -38.5583% | |
| -17.8463% | |
| 37.368% | |
| 43.4358% | |
| 47.5018% | |
| 68.5603% | |
| 77.5653% | |
| 77.5937% | |
| 82.8769% | |
| 76.3828% | |
| 40.3385% | |
| 42.7228% | |
| -318.1953% | |
| -350.285% | |
| 29.8443% | |
| 31.2665% | |
| 32.3778% | |
| 67.8208% | |
| 51.7216% | |
| 54.1909% |